NOVUS THERAPTCS Balance Sheet - Quarterly (NASDAQ:NVUS)

Add to My Stocks
$4.85 $0 (0%) NVUS stock closing price Sep 20, 2018 (Closing)

The NOVUS THERAPTCS balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. How cash on hand has increased or decreased is one of the many indicators used while undertaking the NOVUS THERAPTCS stock analysis, and provides insights into the firm's financial performance. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The balance sheet shows total liabilities of $1.45M and shareholders equity of $21.51M. NOVUS THERAPTCS revenue and NOVUS THERAPTCS operating cash flow are important in understanding the financial capacity of the company.

View and download NOVUS THERAPTCS quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities------4.17M16.08M31.77M39.94M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets1.89M1.5M1.69M1.94M2.33M1.23M1.99M1.61M2.25M2.73M
Total Current Assets
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable--------1.84M1.88M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses-1.17M1.02M2.11M2.78M2.14M2.38M5.45M5.97M4.29M
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus55.01M54.6M46.95M46M45.85M196.6M196.23M195.89M195.24M194.25M
Retained Earnings-33.5M-30.31M-27.5M-25.39M-22.42M-173.26M-169.39M-165.66M-156.39M-142.86M
Treasury Stock----------
Other Liabilities----------0.01M
Shareholders Equity21.51M24.29M19.45M20.61M23.43M23.36M26.85M30.25M38.88M51.4M
Total Liabilities & Shareholders Equity22.97M25.91M20.89M23.01M26.84M25.83M29.76M36.72M46.85M57.71M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at NOVUS THERAPTCS historical stock prices and the current NOVUS THERAPTCS stock price can tell you how the stock price has moved, whereas the NOVUS THERAPTCS PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: NVUS total assets, which was at $22.97M for 2018 Q2 is a balance sheet item representing value of what NOVUS THERAPTCS owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case NOVUS THERAPTCS's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for NVUS stock stand at $1.45M.

NOVUS THERAPTCS Balance Sheet - Key Ratios